Cannacord Lowers Price Target for MedMen Enterprises (CSE: MMEN)

Browse By

Cannacord Genuity lowered MedMen’s (CSE: MMEN, OTC: MMNFF) price target on November 27th, 2019 to $1.00. This represents 96% upside from current price of $0.51 (at the time of reporting). Previous price target was C$3.75, which was lowered from C$6.75 on October 9th, 2019.

About a year ago, MedMen’s consensus target price was C$9.04 on November 4th, 2018. (Market Realist)

MedMen is currently trading at C$0.51 representing 12% decrease from yesterday’s close.

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information and may or may not own shares in the company.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.